MONTERA, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 3.749
NA - Nord America 662
EU - Europa 329
OC - Oceania 14
SA - Sud America 9
AF - Africa 5
Totale 4.768
Nazione #
SG - Singapore 3.334
US - Stati Uniti d'America 625
HK - Hong Kong 187
CN - Cina 178
IT - Italia 103
GB - Regno Unito 96
DE - Germania 50
CA - Canada 30
IN - India 25
CZ - Repubblica Ceca 21
AU - Australia 13
NL - Olanda 13
FR - Francia 8
EE - Estonia 7
FI - Finlandia 7
MX - Messico 7
TR - Turchia 6
UA - Ucraina 5
JP - Giappone 4
CL - Cile 3
SA - Arabia Saudita 3
SE - Svezia 3
TW - Taiwan 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AT - Austria 2
BR - Brasile 2
MK - Macedonia 2
PL - Polonia 2
RS - Serbia 2
AZ - Azerbaigian 1
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
DZ - Algeria 1
EC - Ecuador 1
ES - Italia 1
FK - Isole Falkland (Malvinas) 1
ID - Indonesia 1
IE - Irlanda 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
LB - Libano 1
LT - Lituania 1
NG - Nigeria 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 4.768
Città #
Hong Kong 187
Singapore 167
Ashburn 161
Boardman 93
Hefei 91
London 85
Shanghai 57
Santa Clara 53
Rome 50
Munich 27
Brno 21
Los Angeles 21
San Francisco 21
Pune 17
Buffalo 16
Washington 15
Montreal 14
Toronto 14
Council Bluffs 12
Amsterdam 11
Secaucus 10
Grumo Nevano 9
Seattle 8
Canberra 6
Coral Springs 6
Brooklyn 5
Milan 5
Boston 4
Catania 4
Chicago 4
Paris 4
Temecula 4
Turku 4
Cusano Milanino 3
Melbourne 3
Mexico City 3
Mysore 3
Naples 3
Newark 3
Riyadh 3
Taipei 3
Berlin 2
Brusaporto 2
Buford 2
Charlotte 2
Chihuahua City 2
Dubai 2
Edinburgh 2
Elk Grove Village 2
Guangzhou 2
Haikou 2
Helsinki 2
Hyderabad 2
Linköping 2
Novi Sad 2
San Jose 2
Skopje 2
Sydney 2
São Paulo 2
The Dalles 2
Tokyo 2
Wandsworth 2
Warsaw 2
Zhengzhou 2
Andover 1
Ankara 1
Arlington 1
Atlanta 1
Auckland 1
Baghdad 1
Bratislava 1
Buenos Aires 1
Calgary 1
Chengdu 1
Chennai 1
Chungathara 1
Cicciano 1
Cleveland 1
Clifton 1
Cosenza 1
Dongguan 1
Dublin 1
Guidonia 1
Haifa 1
Handan 1
Huntington 1
Jinan 1
Johannesburg 1
Kunming 1
Lagos 1
Lincoln 1
Linyi 1
Livingston 1
Louisville 1
L’Aquila 1
Minsk 1
Nanjing 1
New York 1
Oklahoma City 1
Paternò 1
Totale 1.312
Nome #
A randomized controlled trial comparing four versus six courses of adjuvant platinum-based chemotherapy in locally advanced cervical cancer patients previously treated with neo-adjuvant chemotherapy plus radical surgery 202
Assessment of quality of life and urinary and sexual function after radical hysterectomy in long-term cervical cancer survivors 193
Efficacy of termoablative fractional CO2 laser (Monnalisa Touch) in stress urinary incontinence 192
Feasibility and efficacy of Letrozole in heavily pre-treated patients with relapsed ovarian cancer not eligible for further chemotherapy cycles 191
Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma 191
Does HE4 have a role as biomarker in the recurrence of ovarian cancer? 182
Does HE4 have a role in the recurrence of ovarian cancer? 180
Anterior colporrhaphy plus inside-out tension-free vaginal tape for associated stress urinary incontinence and cystocele: 10-year follow up results 172
Intravesical Instillations of Hyaluronic Acid as First-Line Treatment in Patients with Interstitial Cystitis/Bladder Pain Syndrome: Use, Efficacy and Effects on Quality of Life 171
Chemotherapy as adjuvant treatment for intermediate-high risk early-stage endometrial cancer a pilot study 165
Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer? 158
Antiangiogenics and immunotherapies in cervical cancer: an update and future's view 157
Early Mini-Invasive Treatment of Persistent Cervical Dysplasia: Clinical Outcome and Psycho-Relational Impact 102
A critical review on HE4 performance in endometrial cancer: where are we now? 99
An ultra-miniinvasive treatment for stress urinary incontinence in complicated older patients 96
Role of Protopine and Nuciferine in the Management of Nocturia, Urgency, and Dysuria in Pre- and Postmenopausal Women: A Prospective Pilot Study 93
Effectiveness of human epididymis protein 4 (HE4) as predictor of response to first line platinum based chemotherapy 87
C-reactive protein "at first sight": Standard postoperative trend in gynecological surgery and a comparative analysis with white blood cell levels 86
A gastrointestinal stromal tumor presenting as a pelvic mass: A case report 84
Bladder function after laparoscopic nerve-sparing radical hysterectomy 84
Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature 84
A new type of absorbable barbed suture for use in laparoscopic myomectomy 84
Does Extensive Upper Abdomen Surgery During Primary Cytoreduction Impact on Long-term Quality of Life? 83
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 81
Aortic lymphadenectomy in cervical cancer: Anatomy, classification and technique 80
Implementing the Risk of Endometrial Malignancy Algorithm (REM) adding obesity as a predictive factor: Results of REM-B in a single-center survey 80
Pelvic-cutaneous fistula after retropubic vaginal tape placement 78
The use of sealing hemostat patch (HEMOPATCH®) in laparotomic myomectomy: a prospective case-control study 77
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 76
Impact of COVID-19 Pandemic on the Diagnostic and Therapeutic Management of Endometrial Cancer: A Monocentric Retrospective Comparative Study 72
Long-term follow-up of bulking agents for stress urinary incontinence in older patients 72
Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma? 52
Influence of pneumoperitoneum pressure on surgical field during robotic and laparoscopic surgery: a comparative study 29
Sacral neuromodulation after stabilization of L2-S1 vertebrae with metallic fixation devices: is it feasible? 28
The Role of HE4, a Novel Biomarker, in Predicting Optimal Cytoreduction After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer 26
Ovarian cancer relapse: From the latest scientific evidence to the best practice 24
Tension-free vaginal tape versus transobturator suburethral tape: Five-year follow-up results of a prospective, randomised trial 24
Utility of tumor marker HE4 as prognostic factor in endometrial cancer: a single-center controlled study 24
REM (Risk of Endometrial Malignancy): a proposal for a new scoring system to evaluate risk of endometrial malignancy 24
Sentinel lymph node in cervical cancer: a literature review on the use of conservative surgery techniques 24
Effectiveness of CO2 laser on urogenital syndrome in women with a previous gynecological neoplasia: a multicentric study 23
Tailoring parametrectomy for early cervical cancer (Stage IA-IIA FIGO): a review on surgical, oncologic outcome and sexual function 23
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset 22
Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer 21
Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4 21
The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review 21
Quality of life in platinum-sensitive recurrent ovarian cancer: chemotherapy versus surgery plus chemotherapy 21
METODO PER LA DETERMINAZIONE DI UN INDICE PREDITTIVO DEL RISCHIO DI TUMORE DELL’ENDOMETRIO 21
Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature 20
Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial 20
Ten years of HPV vaccines: State of art and controversies 20
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 20
Update on lymphadenectomy in early and advanced ovarian cancer 19
Role of human epididymis protein 4 (HE4) in detecting recurrence in CA125 negative ovarian cancer patients 19
The effects of giving patients verbal or written pre-operative information in gynecologic oncology surgery: a randomized study and the medical-legal point of view 19
Use of Sensor Array Analysis to Detect Ovarian Cancer through Breath, Urine, and Blood: A Case-Control Study 18
Hormone replacement therapy in cancer survivors: Utopia? 18
The use of novel hemostatic sealant (Tisseel (R)) in laparoscopic myomectomy: a case-control study 18
The role of macroplastique implantation in the management of occult urinary stress incontinence 18
Use of liposome encapsulated doxorubicin citrate (LEDC) as a valid drug in patients affected by ovarian cancer suffering from chemotherapy side-effects 18
Real-time infrared thermography for ureter detection during hysterectomy 18
Learning curves of a resident surgeon performing transobturator tape procedures for stress urinary incontinence 17
Surgical treatment of rectovaginal endometriosis with extensive vaginal infiltration: results of a systematic three-step vagino-laparoscopic approach 17
Update on urodynamic bladder dysfunctions after radical hysterectomy for cervical cancer 17
The role of novel biomarker HE4 in endometrial cancer: a case control prospective study 17
Use of carboplatinum as neoadjuvant setting for patients affected by locally advanced cervical cancer 17
Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study 17
Surgical primary treatment of stage IVA cervical cancer: A multicentre retrospective study 16
Suburethral sling in autoimmune patients: complications, quality of life, and success rate 16
Post-radical hysterectomy detrusor dysfunctions: is sacral neurostimulation a valid treatment strategy? 14
The novel biomarker HE4 versus CA125 in detecting endometrial cancer: A case control prospective study 14
Use of carboplatinum as neoadjuvant setting for patients affected by locally advanced cervical cancer 14
The role of human epididymis protein 4 as a biomarker in gynecologic malignancies 14
Surgical primary treatment of stage IVA cervical cancer: A multicenter retrospective study. 14
QUALITY OF LIFE IN PLATINUM-SENSITIVE RECURRENT OVARIAN CANCER: CHEMOTHERAPY VERSUS SURGERY PLUS CHEMOTHERAPY 14
Vaginectomy as treatment of isolated vaginal relapse (IVR) of gynecological neoplasms 14
Ureteral injuries management in gynaecologic surgery: the role of the conservative approach 13
The Role of TAP/RS Block in Minor Gynecologic Laparoscopic Surgery: A Randomized Clinical Trial 13
Success rates, quality of life, and feasibility of sacral nerve stimulation in elderly patients: 1-year follow-up 13
Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer 13
Quality of life in patients with endometrial cancer treated with or without systematic lymphadenectomy 13
PROGNOSTIC FACTORS AND BYOCHEMISTRY IN PATIENTS WITH OVARIAN CANCER: A NEW CLINICAL MODEL OF PREDICTION 13
IGCS Intraoperative Technology Taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers 12
Reply from Authors re: Elisabetta Costantini, Massimo Lazzeri. Elephants Can Remember. Eur Urol 2010;58: 678-9 11
The role of peritoneal lavage in benign gynecologic laparoscopic surgery 10
The True Impact of Voiding Dysfunctions after Transobturator Sub-Urethral Tape Procedures: A Systematic Review of Literature 8
Old Issues and New Perspectives on Endometrial Cancer Therapy: How Molecular Characteristics Are Changing the Therapeutic Pathway 8
The Efficacy of CO2 Vaginal Laser in the Treatment of Recurrent, Post-Coital and Interstitial Cystitis: A Multicentric Prospective Study 8
Serous Tubal Intraepithelial Carcinoma (STIC): A Review of the Literature on the Incidence at the Time of Prophylactic Surgery 6
Tailored Treatment Strategies in First Line Therapy for Ovarian Cancer Patients: A Critical Review of the Literature 6
Totale 4.804
Categoria #
all - tutte 32.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.217


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022131 0 0 9 0 0 0 0 4 1 4 0 113
2022/202345 0 1 1 0 1 1 10 2 2 3 16 8
2023/2024443 14 39 28 36 36 137 5 60 8 13 34 33
2024/20254.184 78 22 118 27 25 90 64 43 231 271 1.448 1.767
2025/20261 1 0 0 0 0 0 0 0 0 0 0 0
Totale 4.804